Aijaz Nanjiani
Psychiatry · Paramus, NJNPI 1639266943
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,674 of the $95,019 with a category attached, or 94.4%. AbbVie accounts for 91.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $20,915 and has fallen 57.8% since, to $8,824 in 2025. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $335.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$87K
- Otsuka America Pharmaceutical, Inc.$7K
- Sunovion Pharmaceuticals Inc.$253
- Lundbeck LLC$151
- Johnson & Johnson$28
- Vanda Pharmaceuticals Inc.$27
- plus $44 from 3 others
What the payments were for
- Speaking & faculty fees$89,67494%
- Travel & lodging$230%
- Food & beverage$5,3226%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 219 | $87,172 |
| Otsuka America Pharmaceutical, Inc. | 14 | $7,344 |
| Sunovion Pharmaceuticals Inc. | 26 | $253 |
| Lundbeck LLC | 17 | $151 |
| Johnson & Johnson | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 2 | $27 |
| Bausch Health US, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $15 |
| Validus Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$85,422
- ABILIFY MAINTENA$7,241
How this compares
$95,019 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 231 | $340,367 |
| FanaptIloperidone | 158 | $328,747 |
| IngrezzaValbenazine Tosylate | 12 | $97,179 |
| Chlorpromazine Hcl | 249 | $88,699 |
| Divalproex Sodium ErDivalproex Sodium | 1,276 | $87,542 |
| Invega SustennaPaliperidone Palmitate | 24 | $70,302 |
| Divalproex Sodium | 1,110 | $66,001 |
| NuplazidPimavanserin Tartrate | 12 | $58,973 |
| AristadaAripiprazole Lauroxil | 16 | $52,549 |
| Risperidone | 2,661 | $49,247 |
| Aripiprazole | 932 | $48,169 |
| Quetiapine Fumarate | 1,426 | $44,728 |
| RexultiBrexpiprazole | 32 | $44,671 |
| NuedextaDextromethorphan Hbr/Quinidine | 28 | $43,889 |
| Fluvoxamine Maleate | 688 | $33,582 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Namzaric | $87,172 | $348,042243 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $27 | $328,747158 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $7,344 | $74,69944 claims |
| Johnson & JohnsonInvega Sustenna | $28 | $70,30224 claims |
| Alkermes, Inc.Aristada | $15 | $52,54916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Paramus
- Yasir AhmadParamus$39K
- Joel FederbushParamus$11K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.